Target intelligence / Profile preview

Hepatitis B virus PreS2 domain (PreS2)

Target
PreS2
Molecular classification
Viral envelope protein, Viral surface protein
01

Overview

The Hepatitis B virus (HBV) PreS2 domain is a 55-amino acid segment found in the Middle (M) and Large (L) surface proteins (UniProt P03142). It is essential for the assembly and secretion of viral particles and contains a binding site for polymerized human serum albumin, which may assist in viral attachment (PubMed: 2553345). Mutations in the PreS2 promoter or coding sequence are strongly linked to the development of hepatocellular carcinoma (HCC) by inducing endoplasmic reticulum stress and oxidative DNA damage (PubMed: 22439110). As a therapeutic target, the PreS2 domain is included in third-generation recombinant vaccines like PreHevbrio to enhance the immune response in non-responders to conventional vaccines (FDA, 2021). These vaccines elicit anti-PreS2 antibodies that contribute to viral neutralization and long-term protection against HBV infection (PubMed: 34914883).

Other names
Pre-S2 regionMiddle surface protein domainHBV PreS2MHBV PreS2Hepatitis B virus envelope protein PreS2
02

Mechanism of action

Induction of neutralizing antibodies that block viral attachment and entry into hepatocytes; enhancement of T-cell mediated immune responses (PubMed: 34914883).

03

Biological functions

Viral entryViral assemblyViral secretionImmune response inductionReceptor binding
04

Disease associations

Hepatitis B infectionHepatocellular carcinomaLiver cirrhosisOccult hepatitis B infection
05

Safety considerations

Sequence variabilityImmune escape mutationsER stress induction by mutant forms (PubMed: 22439110)
06

Interacting drugs

Hepatitis B vaccine (recombinant, tri-antigenic)

2 more in the full profile.

07

Biomarkers

Anti-PreS2 antibodiesPreS2 antigen levels

Beyond the preview

Go deeper on Hepatitis B virus PreS2 domain (PreS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatitis B virus PreS2 domain (PreS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call